Experts have suggested the emerging technology could be a “pivotal” tool for the future of breast cancer detection. 

Chatbots may be able to accurately explain MRI results to patients in ways that radiologists are not routinely available to do. 

Gadoquatrane is now set to go through the regulatory review process on its trek to earning full FDA approval. 

If left untreated, SDH expansion puts added pressure on the brain, which can lead to damage, impaired neurological function and even death. 

Placenta accreta spectrum is a serious and sometimes deadly perinatal complication. Instances of the condition have risen in recent decades, potentially due to an increase in cesarean deliveries.

FDA 510(k) clearance does not require that AI devices are subject to prospective human studies prior to approval.

CDC Director Susan Monarez, PhD, was less than a month into her role, having been confirmed by the U.S. Senate on July 30. Her lawyers said the staffing shakeup was a result of HHS Secretary Robert F. Kennedy Jr. “weaponizing public health for political gain.”

Radiologists and other physicians recently wrote to Administrator Mehmet Oz, MD, asking for changes related to contrast-enhanced ultrasound. 

Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.